Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS

Publication ,  Journal Article
Komura, K; Yanaba, K; Horikawa, M; Ogawa, F; Fujimoto, M; Tedder, TF; Varga, J; Sato, S
Published in: Clinical and Experimental Rheumatology
2010

Duke Scholars

Published In

Clinical and Experimental Rheumatology

ISSN

0392-856X

Publication Date

2010

Volume

28

Issue

2

Start / End Page

S74 / S74

Related Subject Headings

  • Arthritis & Rheumatology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Komura, K., Yanaba, K., Horikawa, M., Ogawa, F., Fujimoto, M., Tedder, T. F., … Sato, S. (2010). CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS. Clinical and Experimental Rheumatology, 28(2), S74–S74.
Komura, K., K. Yanaba, M. Horikawa, F. Ogawa, M. Fujimoto, T. F. Tedder, J. Varga, and S. Sato. “CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS.” Clinical and Experimental Rheumatology 28, no. 2 (2010): S74–S74.
Komura K, Yanaba K, Horikawa M, Ogawa F, Fujimoto M, Tedder TF, et al. CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS. Clinical and Experimental Rheumatology. 2010;28(2):S74–S74.
Komura, K., et al. “CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS.” Clinical and Experimental Rheumatology, vol. 28, no. 2, 2010, pp. S74–S74.
Komura K, Yanaba K, Horikawa M, Ogawa F, Fujimoto M, Tedder TF, Varga J, Sato S. CD19 REGULATES THE DEVELOPMENT OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS. Clinical and Experimental Rheumatology. 2010;28(2):S74–S74.

Published In

Clinical and Experimental Rheumatology

ISSN

0392-856X

Publication Date

2010

Volume

28

Issue

2

Start / End Page

S74 / S74

Related Subject Headings

  • Arthritis & Rheumatology
  • 1103 Clinical Sciences